Brief: McKesson Q3 Adjusted EPS USD 8.03 Vs. IBES Estimate USD 7.99
Feb 05 (Reuters) - McKesson Q3 revenue USD 95,294 million vs. IBES estimate USD 96,081 million. * Q3 adjusted net income USD 1,016 million vs. IBES estimate USD 1,018 million * Q3 EPS USD 6.95 * Q3 operating income USD 1,293 million * outlook FY adjusted EPS USD 32.55-32.95
Recent news on McKesson
See all newsMedia: McKesson's medical unit prices $2.25 billion leveraged loan ahead of IPO- Bloomberg News
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson
McKesson expects 2027 profit slightly above estimates on drug distribution strength
McKesson beats Q4 profit estimates, maintains long-term profit growth forecast
Brief: McKesson Q4 Adjusted EPS USD 11.69 Vs. IBES Estimate USD 11.6